600 patients66,869 observations120 daysLIVE

Patient P-01681

Synthetic patientNBL-101 · Day 114 · 55–64 · M · baseline S03Open companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S03
  2. Day 13 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days
  • Toxicity-10
  • Inflammatory activity-7
  • Nutritional resilience+6
  • Treatment adherence-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Drug metabolism and exposure 40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 25
      • WearableResting HR 75 bpm
    • Inflammatory signalling 20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 3 · butyrate capacity 52/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    54 ms
    Sleep
    7.7 h
    Steps
    6,544
    Resting HR
    75 bpm
    Daily log: GI score 16, nutritional resilience 68, adherence 89.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0159457%S0332
    P-0185357%S0339
    P-0168056%S0834
    P-0131454%S1521
    P-0141654%S1432
    P-0169154%S0235
    P-0144953%S1128
    P-0158453%S1433
    P-0163653%S1830
    P-0133851%S1929
    P-0135751%S1431
    P-0152451%S1536